Inventor · disambiguated record
Christopher M. Starr
Also filed as: STARR CHRISTOPHER · STARR CHRISTOPHER M
21 granted patents·16 pending applications·434 citations·filing 1992–2023
96Inventor score
Top patents by PatentIndex Score
37 records- 0196US8546319B2Use of p97 as an enzyme delivery system for the delivery of therapeutic lysosomal enzymesSTARR CHRISTOPHER M·Filed 2010·Granted Oct 1, 2013·25 cites·10 claims
- 0292US8877714B2Compositions comprising receptor-associated protein (RAP) variants specific for LRP2 and uses thereofSTARR CHRISTOPHER M·Filed 2006·Granted Nov 4, 2014·12 cites·25 claims
- 0391US7560431B2Methods of increasing delivery of active agents to brain comprising administering receptor associated protein (RAP) fragments conjugated to active agentsRAPTOR PHARMACEUTICAL INC·Filed 2005·Granted Jul 14, 2009·16 cites·12 claims
- 0491US6569661B1Recombinant α-L-iduronidase, methods for producing and purifying the same and methods for treating diseases caused by deficiencies thereofBIOMARIN PHARM INC·Filed 2000·Granted May 27, 2003·63 cites·10 claims
- 0590US7569544B2Methods of increasing delivery of active agents to brain comprising administering receptor associated protein (RAP) fragments conjugated to active agentsRAPTOR PHARMACEUTICAL INC·Filed 2004·Granted Aug 4, 2009·29 cites·12 claims
- 0689US10995842B1Pulley with hinged side plateSUMMIT RESCUE INC·Filed 2020·Granted May 4, 2021·8 cites·21 claims
- 0789US5672881ACharge-coupled device imaging apparatusGLYKO INC·Filed 1996·Granted Sep 30, 1997·176 cites·8 claims
- 0887US9062126B2Compositions comprising receptor-associated protein (RAP) variants specific for CR-containing proteins and uses thereofZANKEL TODD C·Filed 2006·Granted Jun 23, 2015·11 cites·47 claims
- 0987US8795627B2Treatment of liver disorders by administration of RAP conjugatesSTARR CHRISTOPHER M·Filed 2007·Granted Aug 5, 2014·12 cites·27 claims
- 1086US8440629B2Cyclic receptor-associated protein (RAP) peptidesSTARR CHRISTOPHER M·Filed 2008·Granted May 14, 2013·10 cites·20 claims
- 1186US7829537B2Receptor associated protein (RAP) conjugatesRAPTOR PHARMACEUTICALS INC·Filed 2009·Granted Nov 9, 2010·6 cites·13 claims
- 1279US8609103B2Megalin-based delivery of therapeutic compounds to the brain and other tissuesZANKEL TODD C·Filed 2010·Granted Dec 17, 2013·3 cites·17 claims
- 1377US6972124B2Precursor of N-acetylgalactosamine-4-sulfatase, methods of treatment using said enzyme and methods for producing and purifying said enzymeBIOMARIN PHARM INC·Filed 2003·Granted Dec 6, 2005·8 cites·5 claims
- 1474US2020188522A1Use of p97 as an enzyme delivery system for the delivery of therapeutic lysosomal enzymesBIOASIS TECHNOLOGIES INC·Filed 2019·Application pending·0 cites
- 1573US11613424B1Waste transfer facilityPOLOWNIAK SHAWN·Filed 2021·Granted Mar 28, 2023·1 cites·13 claims
- 1672US9879064B2Compositions comprising receptor-associated protein (RAP) variants specific for CR-containing proteins and uses thereofHORIZON ORPHAN LLC·Filed 2015·Granted Jan 30, 2018·1 cites·12 claims
- 1769US10716862B2Use of P97 as an enzyme delivery system for the delivery of therapeutic lysosomal enzymesBIOASIS TECHNOLOGIES INC·Filed 2017·Granted Jul 21, 2020·0 cites·3 claims
- 1869US2014105880A1Use of p97 as an enzyme delivery system for the delivery of therapeutic lysosomal enzymesBIOASIS ADVANCED TECHNOLOGIES INC·Filed 2013·Application pending·0 cites
- 1963US6866844B2Precursor N-acetylgalactosamine-4-sulfatase, methods of treatment using said enzyme and methods for producing and purifying said enzymeBIOMARIN PHARM INC·Filed 2002·Granted Mar 15, 2005·2 cites·47 claims
- 2060US5258295AFluorophore-assisted cloning analysisGLYKO INC·Filed 1992·Granted Nov 2, 1993·19 cites·13 claims
- 2160US2023202753A1Waste transfer facilityPOLOWNIAK SHAWN·Filed 2023·Application pending·0 cites
- 2259US2005158296A1Use of p97 as an enzyme delivery system for the delivery of therapeutic lysosomal enzymesFiled 2003·Application pending·0 cites
- 2359US2012066816A1Disposable elbow sleeve for sneezing and coughingSTARR CHRISTOPHER·Filed 2011·Application pending·0 cites
- 2459US2005287133A1Precursor N-acetylgalactosamine-4 sulfatase, methods of treatment using said enzyme and methods for producing and purifying said enzymeBIOMARIN PHARM INC·Filed 2005·Application pending·0 cites
- 2558US2009191178A1Manufacture of Highly Phosphorylated Lysosomal Enzymes and Uses ThereofBIOMARIN PHARM INC·Filed 2008·Application pending·0 cites
- 2656US2005026823A1Use of the chaperone receptor-associated protein (RAP) for the delivery of therapeutic compounds to the brain and other tissuesBIOMARIN PHARM INC·Filed 2003·Application pending·0 cites
- 2754US5716508AUtilization of additives and defined storage systems to increase the stability and performance of electrophoresis mediaGLYKO INC·Filed 1993·Granted Feb 10, 1998·14 cites·6 claims
- 2854US2018118802A1Compositions comprising receptor-associated protein (rap) variants specific for cr-containing proteins and uses thereofHORIZON ORPHAN LLC·Filed 2017·Application pending·0 cites
- 2951US2008260715A1Precursor N-acetylgalactosamine-4 sulfatase, methods of treatment using said enzyme and methods for producing and purifying said enzymeBIOMARIN PHARM INC·Filed 2007·Application pending·0 cites
- 3049US2005100539A1Enzymes useful for treating and methods for treating MPS-VI and cells lines for producing such enzymes recombinantlyFiled 2003·Application pending·0 cites
- 3148US5660702AUtilization of additives and defined storage systems to increase the stability and performance of electrophoresis mediaGLYKO INC·Filed 1995·Granted Aug 26, 1997·11 cites·18 claims
- 3247US2008014188A1Manufacture of Highly Phosphorylated Lysosomal Enzymes and Uses ThereofZANKEL TODD C·Filed 2005·Application pending·0 cites
- 3346US2004243436A1Schemes for scheduling patients for a time periodFiled 2003·Application pending·0 cites
- 3446US2006040348A1Methods for producing and purifying recombinant alpha-L-iduronidaseQIN MINMIN·Filed 2003·Application pending·0 cites
- 3545US5591839APolynucleotides encoding α2-3 neuraminidaseGLYKO INC·Filed 1994·Granted Jan 7, 1997·7 cites·10 claims
- 3643US2002146802A1Methods for producing and purifying recombinant alpha-L-iduronidaseFiled 2001·Application pending·0 cites
- 3742US2002048573A1Lytic enzymes useful for treating fungal infectionsFiled 2001·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Christopher M. Starr files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →